We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+24.86%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$129B
AUM Growth
+$2.87B
Cap. Flow
-$22.7B
Cap. Flow %
-17.54%
Top 10 Hldgs %
33.6%
Holding
6,627
New
468
Increased
2,261
Reduced
2,655
Closed
960

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 4.92%
3 Consumer Discretionary 4.46%
4 Healthcare 4.33%
5 Communication Services 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLCA
6301
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-29,300
Closed -$53K
TPHS
6302
DELISTED
Trinity Place Holdings Inc.com
TPHS
$0 ﹤0.01%
+1
New +$2
AINC
6303
DELISTED
Ashford Inc.
AINC
$0 ﹤0.01%
+9
New +$75
WIRE
6304
CALL
DELISTED
Encore Wire Corp
WIRE
-1,100
Closed -$46K
WIRE
6305
PUT
DELISTED
Encore Wire Corp
WIRE
-800
Closed -$34K
ASLN
6306
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
-5
Closed
BIOL
6307
DELISTED
Biolase, Inc.
BIOL
0
ERF
6308
CALL
DELISTED
Enerplus Corporation
ERF
-3,800
Closed -$6K
ERF
6309
PUT
DELISTED
Enerplus Corporation
ERF
-2,900
Closed -$4K
ISUN
6310
DELISTED
iSun, Inc. Common Stock
ISUN
$0 ﹤0.01%
+2
New +$7
ENG
6311
DELISTED
ENGlobal Corp
ENG
0
MDC
6312
PUT
DELISTED
M.D.C. Holdings, Inc.
MDC
-83,484
Closed -$1.79M
AYX
6313
CALL
DELISTED
Alteryx Inc
AYX
-200
Closed -$19K
EXPR
6314
PUT
DELISTED
Express, Inc.
EXPR
-115
Closed -$3K
FGH
6315
DELISTED
FG Group Holdings Inc.
FGH
$0 ﹤0.01%
+20
New +$33
MDRX
6316
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
-1,500
Closed -$11K
SALM
6317
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$0 ﹤0.01%
+24
New +$23
CHS
6318
PUT
DELISTED
Chicos FAS, Inc.
CHS
-1,200
Closed -$2K
TBLT
6319
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
-1
Closed -$8K
NETI
6320
DELISTED
Eneti Inc.
NETI
-1,819
Closed -$46K
FTCH
6321
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-100
Closed -$1K
FTCH
6322
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-400
Closed -$3K
SGEN
6323
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
-9,300
Closed -$1.07M
SGEN
6324
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
-14,000
Closed -$1.61M
HEP
6325
CALL
DELISTED
Holly Energy Partners, L.P.
HEP
-700
Closed -$10K

Similar funds

Barclays's Q2 2020 Portfolio in Review

As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.

  • Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
  • Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
  • Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
  • Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
  • Barclays opened 468 new positions and closed 960 in Q2 2020.
  • Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.

Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.